Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Exscientia Plc (EXAI)
NASDAQ:EXAI
Exscientia Plc (EXAI) Stock Price & Analysis
257 Followers
EXAI Stock Chart & Stats
Day’s Range$3.9 - $4.12
52-Week Range― - ―
Previous Close$3.99
Volume384.65K
Average Volume (3M)N/A
Market Cap
$550.58M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 22, 2024EPS Estimate
-$0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$10.00Price Target Upside148.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Exscientia Plc News
PremiumCompany Announcements
Exscientia plc Calls for 2024 Shareholder Votes
PremiumCompany Announcements
Exscientia Plc Reports Progressive Drug Pipeline
Ownership Overview
0.00%
Insiders
0.14% Mutual Funds
3.05% Other Institutional Investors
96.81% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EXAI FAQ
What was Exscientia Plc’s price range in the past 12 months?
Currently, no data Available
What is Exscientia Plc’s market cap?
Currently, no data Available
When is Exscientia Plc’s upcoming earnings report date?
Exscientia Plc’s upcoming earnings report date is May 22, 2024 which is in 24 days.
How were Exscientia Plc’s earnings last quarter?
Exscientia Plc released its earnings results on Mar 21, 2024. The company reported -$0.42 earnings per share for the quarter, missing the consensus estimate of -$0.344 by -$0.076.
Is Exscientia Plc overvalued?
According to Wall Street analysts Exscientia Plc’s price is currently Undervalued.
Does Exscientia Plc pay dividends?
Exscientia Plc does not currently pay dividends.
What is Exscientia Plc’s EPS estimate?
Exscientia Plc’s EPS estimate is -$0.38.
How many shares outstanding does Exscientia Plc have?
Currently, no data Available
What happened to Exscientia Plc’s price movement after its last earnings report?
Exscientia Plc reported an EPS of -$0.42 in its last earnings report, missing expectations of -$0.344. Following the earnings report the stock price went down -10.496%.
Which hedge fund is a major shareholder of Exscientia Plc?
Among the largest hedge funds holding Exscientia Plc’s share is Platinum Investment Management. It holds Exscientia Plc’s shares valued at 26M.
---
Exscientia Plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (148.14% Upside)
$10.00 (148.14% Upside)
Blogger Sentiment
Bullish
EXAI Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.1M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days <0.1%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.98%
12-Months-Change
Fundamentals
Return on Equity
-35.22%
Trailing 12-Months
Asset Growth
-16.69%
Trailing 12-Months
Company Description
Exscientia Plc
Exscientia PLC is an artificial intelligence-driven pharma tech company committed to discovering, designing, and developing drugs. Its patient-first AI process is comprised of Precision Target, Precision Design, Precision Experiment, and Precision Medicine. Its revenue is generated from Service fees related to drug discovery collaboration agreements it is utilizing its proprietary technology to develop novel Intellectual Property (IP); and Licensing fees related to drug discovery agreements.
---
EXAI Company Deck
---
EXAI Earnings Call
Q4 2024
0:00 / 0:00
---
EXAI Stock 12 Months Forecast
Average Price Target
$10.00
▲(148.14% Upside)
Technical Analysis
Best Analysts Covering EXAI
1 Year
1 Year Success Rate
0/5 ratings generated profit
1 Year Average Return
-36.54%
assigned a buy rating last month
Copying Peter Lawson's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -36.54% per trade.
---